IriSys Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme

– Dr. Yakatan to Discuss: “Where Have All the New Drugs Gone: A Model for Improving the Efficiency and Costs of Pharmaceutical R&D” –


San Diego, May 10, 2017 – IriSys, LLC, a San Diego-based provider of contract pharmaceutical product development and manufacturing services, today announced that Gerald Yakatan, Ph.D., Chairman, CEO and founder of IriSys, will be a featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme in Boston, MA on May 17, 2017. Dr. Yakatan’s talk, “Where Have All the New Drugs Gone: A Model for Improving the Efficiency and Costs of Pharmaceutical R&D,” will describe the custom approach to drug development that helps differentiate IriSys from other contract organizations.

The 7th Clinical Trials Innovation Programme (CTIP): Helping You Achieve Excellence Through Innovation is an invitation-only event for senior executives from the pharmaceutical and biotechnology industries. Companies with representation at the conference are 45% small or startup, 30% mid-size, and 25% large multinational corporations.

“Improving the efficiency and costs of pharmaceutical research and development is important for companies of all sizes and capabilities,” said Gerald Yakatan, Ph.D., IriSys Chairman, CEO and founder. “IriSys has a wide range of U.S. and international clients, partners and collaborators who come to us because we are experienced in bringing products to the market quickly and cost-effectively. Our decades of pharmaceutical R&D expertise allow IriSys to meet or exceed their timelines while accommodating change.”

The CTIP conference attendees span CEOs, Vice Presidents, Directors, and departmental heads. The program includes networking opportunities and one-on-one meetings during which the attendees can confer with Dr. Yakatan and the other “Thought Leaders.”

Dr. Yakatan and his IriSys team are also available to discuss their innovative approach to pharmaceutical development with individuals who are not able to attend the CTIP conference, but would like to learn about options for improving R&D costs and efficiencies. Appointments can be arranged by contacting IriSys at http://www.irisys.com/en/contact-us/.

About IriSys, LLC

IriSys was founded in 1996 to provide contract pharmaceutical product development and manufacturing services, specializing in formulation development, cGMP manufacturing of clinical trial materials and commercial pharmaceutical products, and strategic consulting related to the drug development process. IriSys’ custom approach to drug development is supported by the Company’s scientific and regulatory experience in moving more than 100 drug products from discovery to clinical development and commercialization.

About The 7th Clinical Trials Innovation Programme (https://worldbi.co.uk/CTIPUSA/)
After the success of 6th Clinical Trials Innovation Programme, Miami, World BI is returning with its Flagship 7th Clinical Trials Innovation Programme (CTIP) 2017, this time in Boston, Massachusetts. Introducing the programme in a new way, we are adding themed sessions which will be covering everything from clinical operations to innovations that are changing the paradigm of Clinical Trials. It is an exclusive, invitation only event and each year senior executives from Pharma & Biotech industries converge to this unrivaled platform and forge strong and lasting business relationships.

IriSys Contacts

Louis Scotti
Vice President Business Development
+1-858-281-7943
lscotti@irisys.com

Gwen Rosenberg
Rosenberg Business Communications
+1-858-525-5484
gwen@rosenbergbc.com